About TScan
How We’re Different

Our Approach to Therapy

History of TCR Therapy

About TScan

TScan is dedicated to changing lives by discovering new cancer targets and developing safe and effective T-cell therapies for patients.
Technology
The Discovery Process

The TScan Platform

Technology

Within the tumors of cancer patients are T cells with the ability to recognize and eliminate cancer cells. We are using our proprietary target ID platform to identify the natural targets of tumor-reactive T cells and identify therapeutically active TCRs that are both safe and effective.
Pipeline
Leadership
Executive Team

Board of Directors

Scientific Advisory Board

Investors

Leadership

TScan’s experienced leadership team shares the goal of delivering groundbreaking cancer treatments to patients.
News
Contact
Contact Us

Careers

Contact

For more information about TScan, career or collaboration opportunities.

Unleash immunity

TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system.

How We're Different

News

TScan Therapeutics Announces $100 Million Series C Financing

News

TScan Therapeutics Announces Presentation at the 39th Annual J.P. Morgan Healthcare Conference

News

TScan Therapeutics Announces Publication of Study in Immunity Highlighting the Discovery of Novel T Cell Targets in COVID-19